GITTO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 5.151
AS - Asia 3.538
EU - Europa 3.169
SA - Sud America 804
AF - Africa 97
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.789
Nazione #
US - Stati Uniti d'America 5.066
RU - Federazione Russa 1.313
SG - Singapore 954
CN - Cina 909
BR - Brasile 656
IT - Italia 568
HK - Hong Kong 490
VN - Vietnam 432
PL - Polonia 335
KR - Corea 332
IE - Irlanda 281
FI - Finlandia 160
SE - Svezia 147
FR - Francia 120
IN - India 92
DE - Germania 76
BD - Bangladesh 67
JO - Giordania 64
GB - Regno Unito 59
AR - Argentina 57
ID - Indonesia 55
CA - Canada 37
IQ - Iraq 28
EC - Ecuador 27
JP - Giappone 27
NL - Olanda 27
MX - Messico 26
AU - Australia 25
PY - Paraguay 20
ZA - Sudafrica 17
CH - Svizzera 14
ES - Italia 14
UA - Ucraina 14
PK - Pakistan 13
CI - Costa d'Avorio 12
NG - Nigeria 12
UZ - Uzbekistan 11
CL - Cile 10
CO - Colombia 10
MA - Marocco 10
TR - Turchia 10
PH - Filippine 9
RO - Romania 9
KE - Kenya 8
VE - Venezuela 8
EG - Egitto 7
SA - Arabia Saudita 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
NP - Nepal 6
PE - Perù 6
BJ - Benin 5
CZ - Repubblica Ceca 4
JM - Giamaica 4
PT - Portogallo 4
BO - Bolivia 3
CG - Congo 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
TG - Togo 3
TN - Tunisia 3
AM - Armenia 2
AT - Austria 2
AZ - Azerbaigian 2
BY - Bielorussia 2
DK - Danimarca 2
GT - Guatemala 2
LT - Lituania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
GN - Guinea 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
Totale 12.775
Città #
Santa Clara 1.440
Singapore 742
Ashburn 736
Hong Kong 415
Fairfield 355
Seoul 330
Warsaw 330
Hefei 299
Dublin 280
Ho Chi Minh City 172
San Jose 151
Woodbridge 142
Lawrence 134
Seattle 130
Helsinki 119
Altamura 112
Cambridge 112
Houston 112
Council Bluffs 107
Beijing 103
Florence 93
Chandler 82
Wilmington 81
Moscow 80
Hanoi 78
Los Angeles 78
Lauterbourg 71
Boston 69
Princeton 67
The Dalles 62
Buffalo 61
Dallas 60
São Paulo 55
Mumbai 53
New York 51
Ann Arbor 43
Jakarta 38
San Diego 38
Kent 37
Milan 36
Lappeenranta 33
Rome 33
Shanghai 30
Munich 28
Melbourne 24
Redondo Beach 23
Tokyo 23
Boardman 20
Bologna 20
Da Nang 20
Frankfurt am Main 19
London 19
Chicago 16
Medford 16
Dong Ket 14
Naples 14
Norwalk 14
Bengaluru 13
Rio de Janeiro 13
Abidjan 12
Orem 12
Paris 12
Porto Alegre 12
Abuja 11
Asunción 11
Bern 11
Brasília 11
Haiphong 11
Phoenix 11
Quito 11
Thái Bình 11
West Jordan 10
Yubileyny 10
Amman 9
Atlanta 9
Baghdad 9
Belo Horizonte 9
Chennai 9
City of London 9
Clifton 9
Denver 9
Falls Church 9
Hillsboro 9
Tashkent 9
Timisoara 9
Toronto 9
Can Tho 8
Guangzhou 8
Prato 8
Recife 8
Shenzhen 8
Curitiba 7
Dhaka 7
Elk Grove Village 7
Montreal 7
Salt Lake City 7
San Francisco 7
Siena 7
Barcelona 6
Biên Hòa 6
Totale 8.320
Nome #
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 302
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 262
Adherence to Mediterranean diet in liver transplant recipients: a cross-sectional multicenter study 228
Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients 219
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 219
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 212
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 202
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 196
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status 183
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 182
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 178
Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods 177
Alcohol use disorder and liver transplant: new perspectives and critical issues 176
Oxidative stress–induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk 162
Cellular and molecular mechanisms underlying liver fibrosis regression 159
End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective tips in cirrhotic patients 158
Bioelectrical impedance vector analysis and cardiovascular performance in liver-transplanted recipients 157
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. 153
Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study 151
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients 150
Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer 149
Super-resolution microscopy reveals an altered fibrin network in cirrhosis: The key role of oxidative stress in fibrinogen structural modifications 149
Treatment of nonalcoholic steatohepatitis in adults: Present and future 146
The changing scenario of hepatocellular carcinoma in Italy: an update 145
Needs evaluation questionnaire for liver disease: a novel assessment of unmet needs in patients with chronic liver disease 144
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 143
La prospettiva psicosomatica nella clinica dei trapianti d'organo. 142
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives 142
Unsupervised Exercise Intervention vs. Adherence to a Mediterranean Diet Alone: The Role of Bioelectrical Impedance Vector Analysis and Cardiovascular Performance in Liver-Transplanted Recipients 140
Hepatitis C virus recurrence after liver transplantation: A 10-year evaluation 140
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B. 138
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 137
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 130
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing 129
Pattern of macrovascular invasion in hepatocellular carcinoma 129
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 126
Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times 126
The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease 123
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy 122
Surgical site infection prevention and management in immunocompromised patients: a systematic review of the literature 121
Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation 120
Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis 120
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study 119
Non-alcoholic fatty liver disease and metabolic syndrome after liver transplant 118
Gold standard assays for the monitoring of patients with chronic hepatitis C 117
Frailty after Liver Transplantation: A Complex Unexplored Issue 116
The MELD score in patients awaiting liver transplant: Strengths and weaknesses 116
Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view 116
Real-world analysis on the use of gamma-hydroxybutyric acid for alcohol withdrawal syndrome in hospitalized patients with diagnosis of cirrhosis 115
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 115
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver 114
Hepatic barrage to high-flow, intra-hepatic arteroportal fistulas requiring combined interventional approach 112
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 112
Metabolic Disorders After Liver Transplantation 112
Reproductive Status Is Associated with the Severity of Fibrosis in Women with Hepatitis C 112
Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems 111
Metabolic Disorders in Liver Transplant Recipients: The State of the Art 110
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease article 110
Biological therapies in patients with liver disease: are they really lifesavers? 110
Multidisciplinary view of alcohol use disorder: From a psychiatric illness to a major liver disease 109
Alcohol and viral hepatitis: A mini-review 109
Liver transplantation from hepatitis B surface antigen positive donors: A safe way to expand the donor pool 109
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives 109
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? 108
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18 107
From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic 107
Hepatitis B virus-related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review 105
Microbiota and viral hepatitis: State of the art of a complex matter 104
Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines 103
Vitamins in the treatment of chronic viral hepatitis 103
Virological Treatment Monitoring for Chronic Hepatitis B 102
Stem cells for end stage liver disease: How far have we got? 101
Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients? 101
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver 100
Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: Sequence analysis and therapeutic strategy 99
Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation 98
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC 98
Physical activity in liver transplant recipients: a large multicenter study 94
Primary biliary cholangitis associated with SARS-CoV-2 infection 93
Familial intrahepatic cholestasis: New and wide perspectives 92
Peginterferon-A-2B plus ribavirin is more effective than peginterferon-A-2A plus ribavirin in menopausal women with chronic hepatitis C 92
Worsening of serum lipid profile after direct acting antiviral treatment 91
Study of the serum metabolomic profile in nonalcoholic fatty liver disease: Research and clinical perspectives 91
Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients 90
Non-alcoholic steatohepatitis and liver transplantation 90
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 88
NS5A inhibitors for the treatment of hepatitis C infection 88
Liver transplantation and nonalcoholic steatohepatitis: the state of the art 86
Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis C 86
Liver transplantation for patients with alcoholic liver disease: An open question 85
Impact of psychosocial status on liver transplant process 83
Hepatitis C: clinical management and debated issues 83
HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective study 82
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 82
Influence of age and gender before and after liver transplantation 81
Hepatitis C Virus-related chronic liver disease in elderly patients: An Italian cross-sectional study 80
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: A single center case-control study 79
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients 78
Letter: TNFα inhibitors and prevalence of fatty liver disease in chronic inflammatory diseases 75
In response 75
Totale 12.558
Categoria #
all - tutte 40.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.666


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022445 4 28 58 9 13 5 14 38 40 30 60 146
2022/20231.013 102 287 35 37 25 189 143 48 91 9 30 17
2023/2024515 12 32 89 20 29 53 16 128 15 62 38 21
2024/20253.990 155 398 202 502 1.129 611 187 135 204 100 149 218
2025/20265.619 478 858 722 799 474 246 603 322 388 380 285 64
Totale 12.951